InsiderDB

Lobbying disclosures · Lobbying report

COR: second_quarter 2026 lobbying report

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

Follow COR
Became public
Jul 20, 2026, 1:57 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 11:10 AM EST

Why this is connected

Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/0c7feb81-f4ba-4e83-9067-1d31f8d6066f/","filing_uuid":"0c7feb81-f4ba-4e83-9067-1d31f8d6066f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0c7feb81-f4ba-4e83-9067-1d31f8d6066f/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Timothy Jenkins","dt_posted":"2026-07-20T13:57:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1909 K Street, NW","registrant_address_2":"12th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":400552654,"url":"https://lda.gov/api/v1/registrants/400552654/","house_registrant_id":null,"name":"BALLARD SPAHR LLP","description":"law firm","address_1":"1909 K Street, NW","address_2":"12th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TIM JENKINS","contact_telephone":"+1 202-661-2224","dt_updated":"2026-07-30T13:18:38.142360-04:00"},"client":{"id":192803,"url":"https://lda.gov/api/v1/clients/192803/","client_id":125,"name":"CENCORA, INC.","general_description":"​Pharmaceutical sourcing and distribution services company","client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71405,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"W","last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142323,"prefix":null,"prefix_display":null,"first_name":"MARIA","nickname":null,"middle_name":null,"last_name":"TRIPPLAAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71405,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"W","last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142323,"prefix":null,"prefix_display":null,"first_name":"MARIA","nickname":null,"middle_name":null,"last_name":"TRIPPLAAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in COR

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.